Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1Classical hematology 1

Conditions

Leukemia 8Leukemia, Myeloid, Acute 6Congenital Abnormalities 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 4Myelodysplastic Syndromes 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Leukemia, Myelomonocytic, Chronic 3Hodgkin Disease 3Sezary Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Intraocular Lymphoma 2

Interventions

fludarabine phosphate 8Cytarabine 8Peripheral Blood Stem Cell Transplantation 7Imatinib Mesylate 5Cyclophosphamide 5Busulfan 5Vorinostat 4Filgrastim 4Etoposide 4Antilymphocyte Serum 4tipifarnib 3sargramostim 3Sorafenib 3Radiotherapy 3Methylprednisolone 3Methotrexate 3Ifosfamide 3Decitabine 3Cyclosporine 3Bortezomib 33-aminopyridine-2-carboxaldehyde thiosemicarbazone 3temsirolimus 2laromustine 2belinostat 2alvocidib 2Vincristine 2Sirolimus 2Mycophenolic Acid 2Interferon-alpha 2Idarubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Blast Crisis × laromustine × Clear all
NCT00070538 2013-07-18

VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies

National Cancer Institute (NCI)

Phase 1 Completed
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00098436 2013-07-18

Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias

National Cancer Institute (NCI)

Phase 1 Completed
25 enrolled
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡